Page last updated: 2024-08-23

staurosporine and Edema

staurosporine has been researched along with Edema in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's1 (16.67)18.2507
2000's1 (16.67)29.6817
2010's3 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Avila, CM; Barreiro, EJ; da Silva, LL; Fraga, CA; Gonçalves, AS; Lopes, AB; Miranda, AL; Romeiro, NC; Sant'Anna, CM1
Alam, MS; Ali, Y; Hamid, H; Hussain, F; Khan, I; Sharma, K; Tantray, MA; Umar, S1
Bolstad, B; Dahlseng Håkonsen, G; Dalhus, M; Gisselbrecht, C; Hennik, P; Herberts, C; Kaasboll, T; Meulendijks, D; Pignatti, F; Salmonson, T; Tzogani, K; Verheijen, R; Wangen, T; Yu, Y1
Kim, CH; Kim, HM; Park, SY; Park, WH1
Gschwendt, M; Kittstein, W; Lindner, D; Marks, F1
Aizu, E; Hosoda, Y; Kato, R; Kiyoto, I; Nakadate, T; Yamamoto, S1

Reviews

1 review(s) available for staurosporine and Edema

ArticleYear
European Medicines Agency review of midostaurin (Rydapt) for the treatment of adult patients with acute myeloid leukaemia and systemic mastocytosis.
    ESMO open, 2019, Volume: 4, Issue:6

    Topics: Administration, Oral; Adult; Antineoplastic Combined Chemotherapy Protocols; Diarrhea; Disease-Free Survival; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Approval; Edema; European Union; Fatigue; Female; fms-Like Tyrosine Kinase 3; Humans; Leukemia, Myeloid, Acute; Male; Mastocytosis, Systemic; Middle Aged; Nausea; Protein Kinase Inhibitors; Randomized Controlled Trials as Topic; Risk Assessment; Staurosporine; Vomiting

2019

Other Studies

5 other study(ies) available for staurosporine and Edema

ArticleYear
Structure-based design and biological profile of (E)-N-(4-Nitrobenzylidene)-2-naphthohydrazide, a novel small molecule inhibitor of IκB kinase-β.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:4

    Topics: Amino Acid Sequence; Animals; Anti-Inflammatory Agents; Benzylidene Compounds; Catalytic Domain; Cell Line; Drug Design; Edema; Female; Humans; Hydrazones; I-kappa B Kinase; Ligands; Male; Mice; Molecular Dynamics Simulation; Molecular Sequence Data; Molecular Weight; Protein Kinase Inhibitors

2011
Synthesis of Novel Oxazolo[4,5-b]pyridine-2-one based 1,2,3-triazoles as Glycogen Synthase Kinase-3β Inhibitors with Anti-inflammatory Potential.
    Chemical biology & drug design, 2016, Volume: 87, Issue:6

    Topics: Animals; Anti-Inflammatory Agents; Cytokines; Disease Models, Animal; Edema; Enzyme Inhibitors; Female; Glycogen Synthase Kinase 3 beta; Male; Nitric Oxide; Rats; Rats, Wistar; Triazoles

2016
Effect of a Korean traditional formulation, Hwaotang, on superoxide generation in human neutrophils, platelet aggregation in human blood, and nitric oxide, prostaglandin E2 production and paw oedema induced by carrageenan in mice.
    Immunopharmacology and immunotoxicology, 2004, Volume: 26, Issue:1

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Blotting, Western; Carrageenan; Cell Degranulation; Cyclooxygenase 1; Cyclooxygenase 2; Cytochalasin B; Dinoprostone; Edema; Female; Gastric Mucosa; Gene Expression; Genistein; Hindlimb; Humans; Indomethacin; Isoenzymes; Korea; Leukotriene B4; Lipopolysaccharides; Macrophages, Peritoneal; Medicine, East Asian Traditional; Membrane Proteins; Mice; N-Formylmethionine Leucyl-Phenylalanine; NADPH Oxidases; Neutrophils; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type II; Pancreatic Elastase; Phosphoproteins; Phosphorylation; Phosphotyrosine; Plant Extracts; Platelet Aggregation; Prostaglandin-Endoperoxide Synthases; Protein Kinase Inhibitors; Staurosporine; Stomach; Superoxides; Tetradecanoylphorbol Acetate; Thromboxane B2

2004
Differential inhibition by staurosporine of phorbol ester, bryostatin and okadaic acid effects on mouse skin.
    Cancer letters, 1992, Sep-30, Volume: 66, Issue:2

    Topics: Alkaloids; Animals; Bryostatins; Cyclosporine; Edema; Ethers, Cyclic; Female; Lactones; Macrolides; Mice; Okadaic Acid; Protein Kinase C; Skin; Staurosporine; Tetradecanoylphorbol Acetate

1992
Differential inhibition by staurosporine, a potent protein kinase C inhibitor, of 12-O-tetradecanoylphorbol-13-acetate-caused skin tumor promotion, epidermal ornithine decarboxylase induction, hyperplasia and inflammation.
    Carcinogenesis, 1989, Volume: 10, Issue:7

    Topics: 9,10-Dimethyl-1,2-benzanthracene; Alkaloids; Animals; Edema; Enzyme Induction; Female; Hyperplasia; Inflammation; Kinetics; Mice; Mice, Inbred Strains; Ornithine Decarboxylase; Protein Kinase C; Reference Values; Skin; Skin Neoplasms; Staurosporine; Superoxides; Tetradecanoylphorbol Acetate

1989